Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

NCT02992236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Function Impairment in Healthy Volunteers

Interventions

DRUG: VAS203
DRUG: Saline

Sponsor

veriNOS operations GmbH

Collaborators

[object Object]